The Patent Finder

Neville Pharmaceutical, Inc.

Also on record
Records under this name other than patents Neville Pharmaceutical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Neville Pharmaceutical, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,795,598Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvenation
Lapsed on the fee record
Ended Oct 24, 2021 · USPTO record
Lapsed on the fee recordEnded Oct 24, 2021USPTO record
US 9,549,960Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvination
Lapsed on the fee record
Ended Jan 24, 2021 · USPTO record
Lapsed on the fee recordEnded Jan 24, 2021USPTO record
US 9,439,940Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation
Lapsed on the fee record
Ended Sep 13, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 13, 2020USPTO record
US 9,265,741Molecules to perfect HbA1c levels
Lapsed on the fee record
Ended Feb 23, 2020 · USPTO record
Lapsed on the fee recordEnded Feb 23, 2020USPTO record
US 9,254,250Molecules to perfect HbA1c levels
Lapsed on the fee record
Ended Feb 9, 2020 · USPTO record
Lapsed on the fee recordEnded Feb 9, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited